• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢孟多的实验室及临床研究(作者译)

[Laboratory and clinical studies on cefamandole (author's transl)].

作者信息

Nishimura T, Hiromatsu K, Takashima T, Tabuki K, Kotani Y

出版信息

Jpn J Antibiot. 1979 Sep;32(9):890-900.

PMID:387993
Abstract

The authors have carried out the laboratory and clinical studies of cefamandole (CMD). The results are as follows: The sensitivity was measured by plate dilution method on 26 strains of Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae and 14 strains of Salmonella typhimurium isolated from patients. The distribution of sensitivity of S. aureus was 0.39 approximately 3.13 micrograms/ml and the peak of distribution was 1.56 micrograms/ml. The distribution of sensitivity of E. coli was 0.78 approximately greater than 100 micrograms/ml, and K. pneumoniae, 1.56 approximately greater than 100 micrograms/ml. The distribution of sensitivity of Salmonella typhimurium was 6.25 approximately greater than 100 micrograms/ml and its peak was 6.25 micrograms/ml. CMD were given intravenously for 30 and 60 minutes at a single dose of 25 mg/kg body weight to 6 children. The serum mean levels of CMD were 105.3 micrograms/ml at 30 minutes, 15.1 micrograms/ml at 1.5 hours, 1.6 micrograms/ml at 2.5 hours after drip infusion for 30 minutes, respectively, and 34.7, 5.2, 0.6 micrograms/ml at 1, 2, 3 hours after drip infusion for 60 minutes, respectively. And the serum level at 4 hours after administration was not detected. The mean urinary excretion rates were 73.3% in the drip infusion for 30 minutes and 60.7% in its for 60 minutes, up to 8 hours after administration. Half life was 26 minutes. CMD was effective in 18 of 21 cases of bacterial infections. No side effects were observed except for 2 cases with elevation of serum transaminase.

摘要

作者进行了头孢孟多(CMD)的实验室和临床研究。结果如下:采用平板稀释法对从患者分离出的26株金黄色葡萄球菌、大肠杆菌、肺炎克雷伯菌以及14株鼠伤寒沙门氏菌进行敏感性测定。金黄色葡萄球菌的敏感性分布为0.39至约3.13微克/毫升,分布峰值为1.56微克/毫升。大肠杆菌的敏感性分布为0.78至约大于100微克/毫升,肺炎克雷伯菌为1.56至约大于100微克/毫升。鼠伤寒沙门氏菌的敏感性分布为6.25至约大于100微克/毫升,其峰值为6.25微克/毫升。对6名儿童以25毫克/千克体重的单次剂量静脉注射CMD 30分钟和60分钟。静脉滴注30分钟后,CMD的血清平均水平在30分钟时为105.3微克/毫升,1.5小时时为15.1微克/毫升,2.5小时时为1.6微克/毫升;静脉滴注60分钟后,在1、2、3小时时分别为34.7、5.2、0.6微克/毫升。给药后4小时未检测到血清水平。给药后长达8小时,静脉滴注30分钟时的平均尿排泄率为73.3%,静脉滴注60分钟时为60.7%。半衰期为26分钟。在21例细菌感染病例中,CMD对18例有效。除2例血清转氨酶升高外,未观察到副作用。

相似文献

1
[Laboratory and clinical studies on cefamandole (author's transl)].头孢孟多的实验室及临床研究(作者译)
Jpn J Antibiot. 1979 Sep;32(9):890-900.
2
[Laboratory and clinical studies on cefuroxime (author's transl)].头孢呋辛的实验室及临床研究(作者译)
Jpn J Antibiot. 1979 Dec;32(12):1211-8.
3
[Laboratory and clinical studies of T-1982 (cefbuperazone in pediatric field].T-1982(头孢哌酮在儿科领域的应用)的实验室及临床研究
Jpn J Antibiot. 1983 Apr;36(4):838-48.
4
[Laboratory and clinical studies on cefamandole in pediatric field (author's transl)].头孢孟多在儿科领域的实验室及临床研究(作者译)
Jpn J Antibiot. 1979 Nov;32(11):1091-100.
5
[Laboratory and clinical studies of 6059-S in pediatric field (author's transl)].
Jpn J Antibiot. 1981 May;34(5):800-16.
6
[Laboratory and clinical studies of cefamandole in children (author's transl)].头孢孟多在儿童中的实验室及临床研究(作者译)
Jpn J Antibiot. 1979 Sep;32(9):938-51.
7
[Fundamental and clinical studies of cefamandole sodium in children (author's transl)].头孢孟多酯钠在儿童中的基础与临床研究(作者译)
Jpn J Antibiot. 1979 Sep;32(9):912-29.
8
[Experimental and clinical evaluation of cefpiramide in pediatrics].头孢匹胺在儿科的实验与临床评估
Jpn J Antibiot. 1983 Aug;36(8):2261-8.
9
[Laboratory and clinical studies of cefoperazone in pediatric field (author's transl)].
Jpn J Antibiot. 1980 Sep;33(9):899-909.
10
[Laboratory and clinical studies of cefuzonam in pediatric field].
Jpn J Antibiot. 1987 Feb;40(2):427-38.